Recombinant humanized anti-IgE monoclonal antibody (Shanghai Xiesheng Medicine)

重组抗IgE人源化单克隆抗体（上海谐生）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant humanized anti-IgE monoclonal antibody (Shanghai Xiesheng Medicine)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunosuppressantsImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShanghai Harmony Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Harmony Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A